Telix Pharmaceuticals | TLX - Market Capitalization


Telix Pharmaceuticals reported AUD4.83B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Cochlear AUD 17.05B 2.6B Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Integral Diagnostics AUD 1.08B 457.31M Dec/2024
Mayne Pharma AUD 252.67M 153.55M Dec/2025
Medical Developments International AUD 62.53M 563.29K Dec/2025
Mesoblast USD 2.33B 936.82M Dec/2025
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Pacific Edge NZD 177.94M 16.27M Jun/2026
Paradigm Biopharmaceuticals AUD 145.7M 26.92M Dec/2025
Polynovo AUD 849.74M 24.18M Dec/2025
PYC Therapeutics AUD 965.3M 209.97M Dec/2025
Ramsay Health Care AUD 7.93B 537.83M Dec/2025
ResMed USD 29.75B 17.81B Jul/2026
Sonic Healthcare AUD 11.17B 1.7B Dec/2025